Cargando…
A Critical Review of the Evidence Concerning the HIV Latency Reversing Effect of Disulfiram, the Possible Explanations for Its Inability to Reduce the Size of the Latent Reservoir In Vivo, and the Caveats Associated with Its Use in Practice
Combination antiretroviral therapy (cART) effectively suppresses the replication of human immunodeficiency virus type 1 (HIV-1), improves immune function, and decreases the morbidity of acquired immune deficiency syndrome (AIDS). However, it is unable to eradicate the virus because it does not elimi...
Autor principal: | Knights, Harry D. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390639/ https://www.ncbi.nlm.nih.gov/pubmed/28465838 http://dx.doi.org/10.1155/2017/8239428 |
Ejemplares similares
-
Corrigendum to “A Critical Review of the Evidence Concerning the HIV Latency Reversing Effect of Disulfiram, the Possible Explanations for Its Inability to Reduce the Size of the Latent Reservoir In Vivo, and the Caveats Associated with Its Use in Practice”
por: Knights, Harry D. J.
Publicado: (2019) -
Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal
por: Hayes, Alexander M.L.
Publicado: (2020) -
Latency reversal agents affect differently the latent reservoir present in distinct CD4(+) T subpopulations
por: Grau-Expósito, Judith, et al.
Publicado: (2019) -
A caveat concerning center of resistance
por: Dathe, Henning, et al.
Publicado: (2013) -
Cisplatin resistance reversal by disulfiram and caffeine
por: Kadia, Ashish R., et al.
Publicado: (2016)